The metabolism hypothesis of Alzheimer’s disease: from the concept of central insulin resistance and associated consequences to insulin therapy

The concept of central insulin resistance and dysfunctional insulin signaling in Alzheimer’s disease (AD) has been developed by Siegfried Hoyer in 1985-2000. It is widely recognized that a cerebrometabolic deficiency is one of the most relevant proximate characteristics of sporadic AD, including fun...

Full description

Saved in:
Bibliographic Details
Main Authors: Morgen, Katrin (Author) , Frölich, Lutz (Author)
Format: Article (Journal)
Language:English
Published: 12 February 2015
In: Journal of neural transmission
Year: 2015, Volume: 122, Issue: 4, Pages: 499-504
ISSN:1435-1463
DOI:10.1007/s00702-015-1377-5
Online Access:Verlag, Volltext: http://dx.doi.org/10.1007/s00702-015-1377-5
Verlag, Volltext: https://link-springer-com.ezproxy.medma.uni-heidelberg.de/article/10.1007/s00702-015-1377-5
Get full text
Author Notes:Katrin Morgen, Lutz Frölich

MARC

LEADER 00000caa a2200000 c 4500
001 1565404521
003 DE-627
005 20230427142115.0
007 cr uuu---uuuuu
008 171116s2015 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00702-015-1377-5  |2 doi 
035 |a (DE-627)1565404521 
035 |a (DE-576)495404527 
035 |a (DE-599)BSZ495404527 
035 |a (OCoLC)1340982022 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Morgen, Katrin  |e VerfasserIn  |0 (DE-588)1044344687  |0 (DE-627)771835787  |0 (DE-576)396904327  |4 aut 
245 1 4 |a The metabolism hypothesis of Alzheimer’s disease  |b from the concept of central insulin resistance and associated consequences to insulin therapy  |c Katrin Morgen, Lutz Frölich 
264 1 |c 12 February 2015 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.11.2017 
520 |a The concept of central insulin resistance and dysfunctional insulin signaling in Alzheimer’s disease (AD) has been developed by Siegfried Hoyer in 1985-2000. It is widely recognized that a cerebrometabolic deficiency is one of the most relevant proximate characteristics of sporadic AD, including functional deficits in oxidative glucose breakdown, oxidative stress and amplifying the action of glucocorticoids in the brain. Insulin and insulin receptors are widely distributed in the brain and are impaired in the post-mortem Alzheimer brain. Functionally, altered insulin signaling may promote synaptic dysfunction and impaired connectivity, especially in highly connected and metabolically active regions of the brain, which in turn predisposes towards AD pathology. Thus, the hypothesis has been proposed that defects in the brain insulin signal transduction system and associated consequences, e.g., oxidative stress, are centrally involved in the etiopathogenesis of sporadic AD. Most importantly, in a research field still awaiting substantial progress in therapeutic options, the idea of AD as a brain type of diabetes mellitus is now being translated into clinical trials with promising early results. 
700 1 |a Frölich, Lutz  |d 1956-  |e VerfasserIn  |0 (DE-588)1028327099  |0 (DE-627)730567516  |0 (DE-576)375813160  |4 aut 
773 0 8 |i Enthalten in  |t Journal of neural transmission  |d Wien [u.a.] : Springer, 1950  |g 122(2015), 4, Seite 499-504  |h Online-Ressource  |w (DE-627)300185901  |w (DE-600)1481655-6  |w (DE-576)09450542X  |x 1435-1463  |7 nnas  |a The metabolism hypothesis of Alzheimer’s disease from the concept of central insulin resistance and associated consequences to insulin therapy 
773 1 8 |g volume:122  |g year:2015  |g number:4  |g pages:499-504  |g extent:6  |a The metabolism hypothesis of Alzheimer’s disease from the concept of central insulin resistance and associated consequences to insulin therapy 
856 4 0 |u http://dx.doi.org/10.1007/s00702-015-1377-5  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link-springer-com.ezproxy.medma.uni-heidelberg.de/article/10.1007/s00702-015-1377-5  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20171116 
993 |a Article 
994 |a 2015 
998 |g 1028327099  |a Frölich, Lutz  |m 1028327099:Frölich, Lutz  |d 60000  |e 60000PF1028327099  |k 0/60000/  |p 2  |y j 
998 |g 1044344687  |a Morgen, Katrin  |m 1044344687:Morgen, Katrin  |d 60000  |e 60000PM1044344687  |k 0/60000/  |p 1  |x j 
999 |a KXP-PPN1565404521  |e 2987280467 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Katrin Morgen, Lutz Frölich"]},"relHost":[{"origin":[{"dateIssuedKey":"1950","publisherPlace":"Wien [u.a.]","publisher":"Springer","dateIssuedDisp":"1950-"}],"disp":"The metabolism hypothesis of Alzheimer’s disease from the concept of central insulin resistance and associated consequences to insulin therapyJournal of neural transmission","pubHistory":["1.1950 -"],"part":{"text":"122(2015), 4, Seite 499-504","extent":"6","issue":"4","year":"2015","pages":"499-504","volume":"122"},"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"European Society for Clinical Neuropharmacology","role":"isb"}],"recId":"300185901","titleAlt":[{"title":"Acta neurovegetativa"},{"title":"Journal of neuro-visceral relations"},{"title":"Journal of neural transmission / General section"}],"language":["eng"],"id":{"eki":["300185901"],"zdb":["1481655-6"],"issn":["1435-1463"]},"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 18.10.05"],"title":[{"title":"Journal of neural transmission","title_sort":"Journal of neural transmission"}]}],"origin":[{"dateIssuedDisp":"12 February 2015","dateIssuedKey":"2015"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 16.11.2017"],"person":[{"given":"Katrin","role":"aut","roleDisplay":"VerfasserIn","family":"Morgen","display":"Morgen, Katrin"},{"roleDisplay":"VerfasserIn","family":"Frölich","display":"Frölich, Lutz","given":"Lutz","role":"aut"}],"title":[{"title_sort":"metabolism hypothesis of Alzheimer’s disease","title":"The metabolism hypothesis of Alzheimer’s disease","subtitle":"from the concept of central insulin resistance and associated consequences to insulin therapy"}],"recId":"1565404521","id":{"eki":["1565404521"],"doi":["10.1007/s00702-015-1377-5"]},"language":["eng"],"physDesc":[{"extent":"6 S."}]} 
SRT |a MORGENKATRMETABOLISM1220